Clinical Trial Update: A Study of the Safety and Pharmacokinetics of Levodopa Following Administration of CVT 301 (Levodopa Inhalation Powder) in Adults With Asthma [Phase 1]

View source ↗

Summary

This Phase 1 study reports safety and pharmacokinetics of CVT-301 (levodopa inhalation powder) when administered to adults with asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• CVT-301 (levodopa inhalation powder) (levodopa inhalation powder)

Snippet

Sponsor: Acorda Therapeutics | Conditions: Asthma | Phase 1 | Status: COMPLETED